Valneva SE

Valneva SE
Stock Exchange Frankfurt Stock Exchange
EPS
EUR0.06
Market Cap
EUR295.92 M
Shares Outstanding
77.58 M
Public Float
-
Valneva SE Pfd.
Stock Exchange Euronext Paris
EPS
EUR0.02
Market Cap
EUR7.95 M
Shares Outstanding
17.84 M
Public Float
17.83 M
Valneva SE
Stock Exchange Euronext Paris
EPS
EUR0.06
Market Cap
EUR295.92 M
Shares Outstanding
90.92 M
Public Float
61.14 M
Valneva SE
Stock Exchange Wiener Boerse AG
EPS
EUR0.06
Market Cap
EUR295.92 M
Shares Outstanding
77.58 M
Public Float
-
Valneva SE Pfd.
Stock Exchange Wiener Boerse AG
EPS
-
Market Cap
-
Shares Outstanding
-
Public Float
-

Profile

Address
Campus Bio-Ouest 6
Saint-Herblain Lorraine 44800
France
Employees -
Website http://www.valneva.com
Updated 07/08/2019
Valneva SE is a biotech company which engages in the development, production, and marketing of vaccine and preventive medicine. It operates through the following segments: Commercialized Vaccines, Technologies and Services, and Vaccine Candidates. The Commercialized Vaccines segment includes currently marketed vaccines of the group such as JEV and DUKORAL.

Financials

View All

Frédéric Grimaud
Chairman-Supervisory Board
Bali Muralidhar
Director